Tag: FDA

FDA ends hormone therapy warning, says safe for menopause care

The Food and Drug Administration has made a significant reversal of a decision dating back to 2003 regarding

FDA Recalls Common Blood Pressure Drug For Cancer-Causing Chemicals : ScienceAlert

The recent recall of the blood pressure drug prazosin by the Food and Drug Administration has raised concerns

ACIP hep b vaccine, FDA drug vouchers: Morning Rounds

The Trump administration recently announced a groundbreaking deal that aims to make popular anti-obesity drugs more affordable for

SNAP, NIH, FDA, ACA tax credits, shutdown: Morning Rounds

The latest battle in the indirect costs war In a recent development, the NIH made headlines with its

Microdosing GLP-1 drugs, vaping, FDA drama, : Morning Rounds

The Trump administration has announced that it will partially fund the Supplemental Nutrition Assistance Program (SNAP) for November,

Canada measles, FDA resignation, fluoride: Morning Rounds

Theresa Gaffney is the lead Morning Rounds writer at STAT, focusing on health care, new research, and public

FDA Simplifies Biosimilar Approvals; Patents And Payment Issues Remain

Biosimilars are a type of biologic medication that is designed to be highly similar to an already approved

The NFL, the Q-Collar, and the need for more FDA transparency

The Q-Collar, a neck collar inspired by the woodpecker, has gained popularity among NFL players and young athletes

FDA Is Investigating the Abortion Pill Mifepristone despite Decades of Studies Showing It’s Safe

The announcement by Secretary of Health and Human Services Robert F. Kennedy, Jr., regarding the FDA's review of

FDA restricts use of kids’ fluoride supplements

By LUCY SMITH, Staff Writer WASHINGTON (AP) — The Food and Drug Administration announced on Friday its decision

IVF research, FDA vouchers, dementia: Morning Rounds

The race to secure an FDA priority review voucher is heating up, with the first nine recipients recently

STAT+: Biotech leaders say uncertainty at FDA threatens drug development

Executives from Replimune and Capricor Address FDA Rejections Amid Agency Turmoil Jeff Pinette for STAT Lizzy Lawrence directs